Editorial
doi: 10.1200/JCO.2008.21.2522.
Epub 2008 Dec 29.
Dual-antibody therapy in advanced colorectal cancer: gather ye rosebuds while ye may
- PMID: 19114682
- DOI: 10.1200/JCO.2008.21.2522
Item in Clipboard
Editorial
Dual-antibody therapy in advanced colorectal cancer: gather ye rosebuds while ye may
J Clin Oncol.
.
Erratum in
- J Clin Oncol. 2009 Jun 10;27(17):2892
No abstract available
Comment on
-
Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer.J Clin Oncol. 2009 Feb 10;27(5):663-71. doi: 10.1200/JCO.2008.20.8397. Epub 2008 Dec 29. J Clin Oncol. 2009. PMID: 19114683 Clinical Trial.
-
A randomized phase IIIB trial of chemotherapy, bevacizumab, and panitumumab compared with chemotherapy and bevacizumab alone for metastatic colorectal cancer.J Clin Oncol. 2009 Feb 10;27(5):672-80. doi: 10.1200/JCO.2008.19.8135. Epub 2008 Dec 29. J Clin Oncol. 2009. PMID: 19114685 Clinical Trial.
Similar articles
-
[Application of monoclonal antibody in combination with irinotecan in the treatment of colorectal cancer].Zhonghua Zhong Liu Za Zhi. 2006 Oct;28(10):796-7. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 17366800 Review. Chinese. No abstract available.
-
Targeted therapy for colorectal cancer resistance to EGF receptor antibodies and new trends.Expert Rev Gastroenterol Hepatol. 2013 Jan;7(1):5-8. doi: 10.1586/egh.12.60. Expert Rev Gastroenterol Hepatol. 2013. PMID: 23265143 Review. No abstract available.
-
Targeted therapy for advanced colorectal cancer--more is not always better.N Engl J Med. 2009 Feb 5;360(6):623-5. doi: 10.1056/NEJMe0809343. N Engl J Med. 2009. PMID: 19196680 No abstract available.
-
Systemic therapy for advanced or metastatic colorectal cancer: National Comprehensive Cancer Network guidelines for combining anti-vascular endothelial growth factor and anti-epidermal growth factor receptor monoclonal antibodies with chemotherapy.Pharmacotherapy. 2008 Nov;28(11 Pt 2):18S-22S. doi: 10.1592/phco.28.11-supp.18S. Pharmacotherapy. 2008. PMID: 18980548
-
Antiangiogenesis drug promising for metastatic colorectal cancer.Lancet. 2003 Jun 7;361(9373):1959. doi: 10.1016/S0140-6736(03)13603-3. Lancet. 2003. PMID: 12801743 No abstract available.
Cited by
-
Biomarkers and anti-EGFR therapies for KRAS wild-type metastatic colorectal cancer.Clin Transl Oncol. 2009 Nov;11(11):737-47. Clin Transl Oncol. 2009. PMID: 19917537 Review.
-
Current targeted therapies in the treatment of advanced colorectal cancer: a review.Ther Adv Med Oncol. 2016 Jul;8(4):276-93. doi: 10.1177/1758834016646734. Epub 2016 May 29. Ther Adv Med Oncol. 2016. PMID: 27482287 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
